Long-Term Dietary Changes after Diagnosis of Rheumatoid Arthritis in Swedish Women: Data from a Population-Based Cohort

by Cecilia Lourdudoss, Laurent Arnaud, Alicja Wolk, Ronald F. van Vollenhoven, Daniela Di Giuseppe
Published 2018-01-01

Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials.

by Emilia Quattrocchi, Mikkel Østergaard, Peter C Taylor, Ronald F van Vollenhoven, Myron Chu, Stephen Mallett, Hayley Perry, Regina Kurrasch
Published 2016-01-01

Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis

by Tamarah D. de Jong, Tanja Snoek, Elise Mantel, Conny J. van der Laken, Ronald F. van Vollenhoven, Willem F. Lems
Published 2019-04-01

Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a ful...

by Maike H. M. Wientjes, Sadaf Atiqi, Gerrit Jan Wolbink, Michael T. Nurmohamed, Maarten Boers, Theo Rispens, Annick de Vries, Ronald F. van Vollenhoven, Bart J. F. van den Bemt, Alfons A. den Broeder
Published 2021-06-01